Table 2. Outcomes for different PCA3 thresholds.
Study | Threshold | Threshold relevance |
---|---|---|
[37] | 50 | Identification of men at high risk of harboring significant PCa who are candidates for RP |
[39] | 47 | Providing a correlation between PCA3 score and tumor volume |
[34, 38] | 35 | Optimal balance between sensitivity of 58% and specificity of 72% |
[36] | 35 | Increased risk of PCa |
[41] | 35 | Optimal balance with sensitivity of 54% and specificity of 74% |
[40] | 24 and 35 | Independent predictors in multivariable intermediate-and high-grade disease models |
[42] | 25 | Predictive of pathological indolent PCa |
[43] | 25 | Optimal balance between sensitivity and specificity, and also NPV is greater enhanced |
[44] | 25 | Effective to determine which men are candidates for AS |
[37] | 20 | Selecting men with clinically insignificant PCa in whom AS may be appropriate |
[45] | 17 | Increment in PA to detect PCa |
Abbreviations: RP: radical prostatectomy; PCa: prostate cancer; NPV: negative predictive value; AS: active surveillance: PA: predictive accuracy.